Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/13564
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bach, Leon A | en |
dc.contributor.author | Leeding, K S | en |
dc.contributor.author | Leng, S L | en |
dc.date.accessioned | 2015-05-16T03:26:37Z | |
dc.date.available | 2015-05-16T03:26:37Z | |
dc.date.issued | 1997-11-01 | en |
dc.identifier.citation | The Journal of Endocrinology; 155(2): 225-32 | en |
dc.identifier.govdoc | 9415056 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/13564 | en |
dc.description.abstract | PC12 rat phaeochromocytoma cells are widely used as a model of neuronal differentiation. They express IGF receptors and are responsive to IGFs. The main IGF-binding protein synthesized by these cells is IGFBP-6. Glucocorticoids induce differentiation of PC12 cells towards a chromaffin phenotype. The effect of dexamethasone on IGFBP-6 levels was therefore studied. Dexamethasone (500 nM) decreased IGFBP-6 protein in conditioned media and mRNA levels to 61 +/- 5% (P < 0.0001) and 34 +/- 14% (P = 0.03) of control levels respectively. Incubation of PC12 cells with IGF-II (100 ng/ml) for 72 h increased IGFBP-6 protein levels in media to 217 +/- 19% of control (P < 0.0001). IGFBP-6 mRNA levels, however, were unchanged. IGF-I had similar effects on IGFBP-6 protein and mRNA levels. IGFs increased cell number by 50-60%, but this was insufficient to explain the increases in protein levels. IGFBP-6 was not released from a cell-associated reservoir or protected from proteolysis by IGFs, excluding these post-translational mechanisms as explanations for the IGF effects on IGFBP-6 levels. The effects of IGF-II and dexamethasone on IGFBP-6 levels were independent. These results indicated that (1) dexamethasone decrease IGFBP-6 at the mRNA level, and (2) IGFs stimulate IGFBP-6 levels by a post-transcriptional mechanism. | en |
dc.language.iso | en | en |
dc.subject.other | Animals | en |
dc.subject.other | Blotting, Western | en |
dc.subject.other | Cell Count | en |
dc.subject.other | Cell Differentiation.drug effects | en |
dc.subject.other | Dexamethasone.pharmacology | en |
dc.subject.other | Glucocorticoids.pharmacology | en |
dc.subject.other | Insulin-Like Growth Factor Binding Protein 6.genetics.metabolism | en |
dc.subject.other | Insulin-Like Growth Factor I.pharmacology | en |
dc.subject.other | Insulin-Like Growth Factor II.pharmacology | en |
dc.subject.other | PC12 Cells.drug effects.metabolism | en |
dc.subject.other | RNA, Messenger.analysis | en |
dc.subject.other | Rats | en |
dc.subject.other | Somatomedins.pharmacology | en |
dc.title | Regulation of IGF-binding protein-6 by dexamethasone and IGFs in PC12 rat phaeochromocytoma cells. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | The Journal of Endocrinology | en |
dc.identifier.affiliation | Department of Medicine, University of Melbourne, Austin, Australia | en |
dc.description.pages | 225-32 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/9415056 | en |
dc.type.austin | Journal Article | en |
item.fulltext | No Fulltext | - |
item.openairetype | Journal Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.